Dissociation in the effects of the D2/D3 dopaminergic agonist quinpirole on drinking and on vasopressin levels in the rat

Neurosci Lett. 2002 Jun 7;325(2):79-82. doi: 10.1016/s0304-3940(02)00261-6.

Abstract

In the present study, we investigated the role of vasopressin in the development of quinpirole-induced hyperdipsia in the rat. We report that: (1), an acute intraperitoneal (i.p.) injection of 0.56 mg/kg of quinpirole increased plasma vasopressin (radioimmunoassay) at 15 min but not at 30 or 120 min; (2), nine daily injections of quinpirole (0.56 mg/kg, i.p.) progressively increased water intake and diuresis for a period of several hours after each treatment; (3), quinpirole hyperdipsia was associated with apparently normal levels of vasopressin (which might be considered inappropriately high in the presence of excessive drinking); (4), quinpirole reduced vasopressin and oxytocin, but not angiotensin, immunoreactivity in the supraoptic nucleus. These findings suggest that quinpirole hyperdipsia is a sound animal model of psychotic polydipsia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Diuresis / drug effects
  • Dopamine Agonists / administration & dosage
  • Dopamine Agonists / pharmacology*
  • Drinking / drug effects*
  • Injections, Intraperitoneal
  • Male
  • Oxytocin / antagonists & inhibitors
  • Quinpirole / administration & dosage
  • Quinpirole / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Dopamine D2 / agonists*
  • Receptors, Dopamine D3
  • Supraoptic Nucleus / metabolism
  • Time Factors
  • Vasopressins / antagonists & inhibitors
  • Vasopressins / blood*
  • Vasopressins / metabolism

Substances

  • Dopamine Agonists
  • Drd3 protein, rat
  • Receptors, Dopamine D2
  • Receptors, Dopamine D3
  • Vasopressins
  • Quinpirole
  • Oxytocin